Sectors
ARTL
Artelo Biosciences, Inc.
6.36
2 x 4.68
5 x 6.94
bid
ask
+
0.40
6.63%
4 @ 06:00 PM
6.01 -0.35 (5.50%)
| Ytd | 73.77% | |
| 1y | -77.08% |
5.34
day range
6.79
4.68
52 week range
249.75
| Open | 6.06 | Prev Close | 5.96 | Low | 5.34 | High | 6.79 | Mkt Cap | 3.48M |
| Vol | 586.57K | Avg Vol | 38.93K | EPS | -101.07 | P/E | N/A | Forward P/E | -1.10 |
| Beta | 1.35 | Short Ratio | 1.65 | Inst. Own | 0.72% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 8.34 | 200-d Avg | 30.08 | 1yr Est | 5.00 |
| Income Statement | |||
| Operating Expenses | 2.51M | ||
| Research and Development Expense | 876.00K | ||
| Selling, General and Administrative Expense | 1.63M | ||
| Operating Income | -2.50M | ||
| Interest Expense | 6.00K | ||
| Net Income | -2.43M | ||
| Net Income Common Stock | -2.43M | ||
| Net Income Common Stock (USD) | -2.43M | ||
| Consolidated Income | -2.43M | ||
| Earnings per Basic Share | -0.89 | ||
| Earnings per Basic Share (USD) | -0.89 | ||
| Earnings per Diluted Share | -0.89 | ||
| Earning Before Interest & Taxes (EBIT) | -2.42M | ||
| Earning Before Interest & Taxes (USD) | -2.42M | ||
| Weighted Average Shares | 2.71M | ||
| Weighted Average Shares Diluted | 2.71M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.20M | ||
| Cash and Equivalents (USD) | 4.20M | ||
| Current Assets | 4.37M | ||
| Property, Plant & Equipment Net | 46.00K | ||
| Total Assets | 6.46M | ||
| Debt Current | 42.00K | ||
| Total Debt | 49.00K | ||
| Current Liabilities | 1.46M | ||
| Debt Non-Current | 7.00K | ||
| Total Liabilities | 1.46M | ||
| Accumulated Retained Earnings (Deficit) | -68.40M | ||
| Accumulated Other Comprehensive Income | -242.00K | ||
| Shareholders Equity | 5.00M | ||
| Shareholders Equity (USD) | 5.00M | ||
| Assets Non-Current | 2.09M | ||
| Total Debt (USD) | 49.00K | ||
| Goodwill and Intangible Assets | 2.04M | ||
| Liabilities Non-Current | 7.00K | ||
| Trade and Non-Trade Payables | 1.41M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 9.00K | ||
| Net Cash Flow from Financing | -1.06M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.07M | ||
| Issuance (Purchase) of Equity Shares | 178.00K | ||
| Issuance (Repayment) of Debt Securities | -1.24M | ||
| Net Cash Flow from Operations | -5.03M | ||
| Effect of Exchange Rate Changes on Cash | 22.00K | ||
| Share Based Compensation | 570.00K | ||